Philip Jonathan Casselli Sells 50,000 Shares of Microbix Biosystems Inc. (TSE:MBX) Stock

Microbix Biosystems Inc. (TSE:MBX) Senior Officer Philip Jonathan Casselli sold 50,000 shares of the business’s stock in a transaction that occurred on Wednesday, January 22nd. The stock was sold at an average price of C$0.42, for a total value of C$21,000.00.

Microbix Biosystems Stock Down 3.8 %

Shares of TSE:MBX opened at C$0.50 on Friday. The business’s 50 day moving average is C$0.38 and its 200 day moving average is C$0.35. Microbix Biosystems Inc. has a 12-month low of C$0.29 and a 12-month high of C$0.52. The stock has a market cap of C$68.35 million, a price-to-earnings ratio of 12.50 and a beta of 0.34. The company has a quick ratio of 5.57, a current ratio of 6.62 and a debt-to-equity ratio of 22.68.

Microbix Biosystems Company Profile

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.